๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer

โœ Scribed by Eguchi, Kenji; Etou, Hisashi; Miyachi, Sumiki; Morinari, Hajime; Nakada, Kouichiro; Noda, Kazumasa; Ohkuni, Yoshihiro; Watanabe, Koshiro; Yamada, Yuzuru; Ohe, Yuichiro

Book ID
122790862
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
982 KB
Volume
30
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dose escalation study of carboplatin wit
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan
โœ Nobuyuki Katakami; Minoru Takada; Shunichi Negoro; Katsuyasu Ota; Jiro Fujita; K ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 738 KB

## BACKGROUND. We performed a Phase 1-11 trial to determine the maximum tolerated dose of carboplatin (CBDCA) with a fixed dose of VP-16 and granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC) patients. ## METHODS. Treatment consisted of a starting dose of CBDCA, 400